Depression

>

Latest News

Phase 2b study of Psychedelic Compound BPL-003 Shows Rapid, Persistent, and Significant Improvement in Treatment Resistant Depression / image credit ©fyb/stock.adobe.com
Phase 2b Study of Psychedelic BPL-003 Shows Rapid, Persistent, and Significant Improvement in Treatment Resistant Depression

July 2nd 2025

A single dose of BPL-003 was associated with improved MADRS scores as early as day 2 that were durable through week 8; phase 3 planning is anticipated.

What, Exactly, is Alcohol Use Disorder?
What, Exactly, is Alcohol Use Disorder?

June 16th 2025

Late Life Mood Disorders Show Strong Association with Tau and Amyloid Pathology, Study Reveals
Late-Life Mood Disorders Show Strong Association with Tau and Amyloid Pathology, Study Reveals

June 13th 2025

Postpartum Hormonal Contraceptives Up Depression Risk by 50%: Daily Dose / image credit: ©New Africa/AdobeStock
Postpartum Hormonal Contraceptives Up Depression Risk by 50%: Daily Dose

June 4th 2025

Bringing PPD Screening to the Forefront of Maternal Health: A Q&A with Joy Baker, MD
Bringing PPD Screening to the Forefront of Maternal Health: A Q&A with Joy Baker, MD

June 3rd 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.